Skip to main content

Day: August 24, 2023

LumiraDx Reports Second Quarter 2023 Results

LONDON, Aug. 24, 2023 (GLOBE NEWSWIRE) — LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its second quarter ended June 30, 2023.Second quarter 2023 revenues of $21.0 million Submitted First 510(k) Application to the U.S. Food and Drug Administration (FDA) for 5-minute COVID Ultra test Submitted COVID/Flu combo test for FDA Emergency Use Authorization (EUA) as part of the NIH’s Independent Test Assessment (ITAP) program More than 1,500 new instruments shipped in Q2, primarily to U.S. pharmacy locations to expand testing capacity for the upcoming respiratory seasonRon Zwanziger, Chairman and CEO of LumiraDx, stated, “The submission of our first 510(k) application to the FDA for our COVID Ultra test represents a significant milestone...

Continue reading

Navios Maritime Holdings Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2023

Revenue$81.9 million in Q2 2023 $147.3 million in H1 2023Net Income$15.5 million in Q2 2023 $29.9 million in H1 2023EBITDA, a non-GAAP measure$42.3 million in Q2 2023 $82.8 million in H1 2023GRAND CAYMAN, Cayman Islands, Aug. 24, 2023 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) (NYSE: NM), today reported its financial results for the second quarter and six months ended June 30, 2023. Navios Holdings owns (i) a controlling equity stake in Navios South American Logistics Inc. (“Navios Logistics”), one of the largest infrastructure and logistics companies in the Hidrovia region of South America and (ii) an interest in Navios Maritime Partners L.P. (“Navios Partners”) (NYSE:NMM), an international shipping company, listed on the New York Stock Exchange, that owns and...

Continue reading

Commercial Display Market to Surpass 81.78 Billion by 2030 Drives Due to Rapid Urbanization

SkyQuest projects that the commercial display market will attain a value of USD 81.78 billion by 2030, with a CAGR of 8.28% over the forecast period (2023-2030). The rapid urbanization witnessed in developing economies has resulted in significant growth in the commercial display market. This growth can be attributed to the continuous development of infrastructure and the changing lifestyles of people. Industries such as retail and hospitality are adopting advanced and digitized promotional approaches to advertise their products and services effectively. Westford, USA, Aug. 24, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, continuous technological advancements have revolutionized the commercial display market, leading to the development of advanced software solutions that enhance audience engagement, people counting and tracking,...

Continue reading

Global Patient Handling Equipment Market Size to Reach USD 18.98 Billion in 2032 | Emergen Research

Increasing government funding and product approvals for healthcare is a key factor driving patient handling equipment market revenue growth Vancouver, Aug. 24, 2023 (GLOBE NEWSWIRE) — The global market size of patient handling equipment attained USD 10.40 Billion in 2022, and it is projected to exhibit a revenue Compound Annual Growth Rate (CAGR) of 6.2% throughout the forecast period, as per the latest analysis conducted by Emergen Research. The escalating prevalence of various diseases, the expanding elderly population, and augmented governmental investments in healthcare constitute the principal drivers underpinning the revenue upsurge in the worldwide patient handling equipment market. Moreover, the progression in medical technology stands as an additional catalyst fostering the expansion of this market. An additional influential...

Continue reading

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference in New York City as follows:Date:   Tuesday, September 12, 2023     Time:   8:30 a.m. ET     Webcast:   Click here     To schedule a 1×1 meeting with the Company, please contact meetings@hcwco.com at H.C. Wainwright. The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days. About ANI ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical...

Continue reading

Burlington Stores, Inc. Reports Second Quarter 2023 Earnings

On a GAAP basis, total sales increased 9% Net income was $31 million, and diluted EPS was $0.47 Comparable store sales increased 4% On a non-GAAP basis, Adjusted EBIT was $68 million and Adjusted EPS was $0.60, which included $0.03 per share of expense related to recently acquired Bed Bath & Beyond leasesBURLINGTON, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) —  Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the second quarter ended July 29, 2023. Michael O’Sullivan, CEO, stated, “Our comparable store sales growth for the second quarter was 4%, which was at the high end of our guidance range, while margin and earnings performance were significantly ahead...

Continue reading

Integra Reports Final Oxide Drill Results and Key Observations From Stockpile Drill Program at DeLamar

VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — Integra Resources Corp. (“Integra” or the “Company”) (TSXV: ITR; NYSE American: ITRG) is pleased to announce the remaining drill results from the stockpile drill program at the DeLamar Project (“DeLamar” or the “Project”) located in southwestern Idaho. The stockpile drill program was completed in Q2 2023 and totaled 12,588 meters (“m”) in 321 drill holes. This news release includes results from the remaining 145 drill holes representing 4,244 m. The stockpile drill program at DeLamar was designed to test a large portion of the estimated 60 million tonnes (“Mt”) of gold and silver mineralized material that was stockpiled and/or used as backfill at the Project by previous operators. The Company believes that oxide-and-mixed gold and silver mineralized material from the...

Continue reading

Wallbridge Commences Phase-One Drill Testing of Grasset Gold Targets

Figure 1.Wallbridge’s Detour-Fenelon Gold Trend land package and 2023 priority exploration target areas.Figure 2.Grasset Gold Property, 2023 Exploration Drill Program, Plan ViewCommencing 5,000 metre phase-one drill program at Grasset Gold, located adjacent to the Fenelon Gold Project. Testing 11 high-priority gold targets in the Grasset East Flexure area identified from airborne geophysics that have yet to be drill-tested. The Grasset East Flexure is only one of many grassroots exploration areas with excellent potential to host gold mineralization on Wallbridge’s 830 km2 land position.TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX: WM, OTCQX: WLBMF) (“Wallbridge” or the “Company”) today announced that drill testing on 11 new gold exploration targets at its 100%-owned Grasset...

Continue reading

SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor

CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of Dr. Krishna Bhat, MD. Ph.D., FACC., an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief Medical Advisor. Baron Night, SOHM president and CEO, said Dr. Bhat has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from the American Heart Association, which states: “In recognition of your commitment to excellence in the field of Cardiovascular Care through your leadership as an outstanding physician, researcher, and educator.”...

Continue reading

H World Group Limited Reports Second Quarter and Interim of 2023 Unaudited Financial Results

A total of 8,750 hotels or 844,417 hotel rooms in operation as of June 30, 2023. Hotel turnover1 increased 72.0% year-over-year to RMB20.3 billion in the second quarter of 2023. Excluding Steigenberger Hotels GmbH and its subsidiaries (“DH”, or “Legacy-DH”), hotel turnover increased 78.1% year-over-year in the second quarter of 2023. Revenue increased 63.5% year-over-year to RMB5.5 billion (US$762 million)2 in the second quarter of 2023, surpassing the revenue guidance previously announced of a 51% to 55% increase compared to the second quarter of 2022. Revenue from the Legacy-Huazhu segment in the second quarter of 2023 increased 76.6% year-over-year, exceeding the revenue guidance previously announced of a 64% to 68% increase. Net income attributable to H World Group Limited was RMB1.0 billion (US$138 million) in the second quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.